SCHEMBL1235404

SCHEMBL1235404

CC(C)CCCCCC(=O)OCC(C)(C)COC(=O)CCCCCC(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.42
DGKA P23743 1/20 0.40
P2RY10 O00398 1/20 0.39
GPR34 Q9UPC5 1/20 0.39
KDM4C Q9H3R0 2/20 0.39
KDM4A O75164 1/20 0.39
PHF8 Q9UPP1 1/20 0.39
KDM2A Q9Y2K7 1/20 0.39
LMNA P02545 4/20 0.38
ALDH1A1 P00352 1/20 0.38
CYP3A4 P08684 1/20 0.38
TSHR P16473 1/20 0.38
ATM Q13315 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
PAM P19021 2/20 0.37
KDM4E B2RXH2 1/20 0.37
DUSP3 P51452 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29361777 1.00 MAPT (0.42) MAPTDGKAP2RY10GPR34KDM4C
SCHEMBL2129736 0.98 MAPT (0.40) MAPTDGKAP2RY10GPR34KDM4C
SCHEMBL7560959 0.94 KDM4C (0.45) MAPTP2RY10GPR34KDM4CKDM4A
SCHEMBL26474473 0.94 DGKA (0.43) MAPTDGKAP2RY10GPR34KDM4C
SCHEMBL11104131 0.92 MAPT (0.39) MAPTDGKAP2RY10GPR34KDM4C
SCHEMBL29926571 0.92 MAPT (0.39) MAPTDGKAP2RY10GPR34KDM4C
SCHEMBL5180686 0.90 MAPT (0.37) MAPTDGKAP2RY10GPR34KDM4C
SCHEMBL17581563 0.89 MAPT (0.42) MAPTDGKAKDM4CKDM4APHF8
SCHEMBL17581555 0.89 MAPT (0.42) MAPTDGKAKDM4CKDM4APHF8
SCHEMBL17581545 0.89 MAPT (0.42) MAPTDGKAKDM4CKDM4APHF8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 338 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12508218-B2 Coating compositions COTY INC. (US) 2025-12-30 US claimed
EP-3103523-B1 ABSORBENT ARTICLE COMPRISING FRAGRANCE COMPOSITION PROCTER & GAMBLE (US) 2025-10-29 EP claimed
EP-4486289-A1 COMPOSITIONS AND METHODS FOR CURLY HAIR L'OREAL (FR) 2025-01-08 EP claimed
WO-2023164280-A1 COMPOSITIONS AND METHODS FOR CURLY HAIR RUGHANI RONAK (US) 2023-08-31 WO claimed
EP-3141239-B1 FRAGRANCE COMPOSITIONS AND USES THEREOF PROCTER & GAMBLE (US) 2023-05-10 EP claimed
US-20230098760-A1 FORMULATIONS PROVIDING LONG-LASTING FRAGRANCE PERFORMANCE FIRMENICH SA (CH) 2023-03-30 US claimed
EP-4076362-A1 FORMULATIONS PROVIDING LONG-LASTING FRAGRANCE PERFORMANCE Firmenich SA (CH) 2022-10-26 EP claimed
US-20220304914-A1 COATING COMPOSITIONS JPMORGAN CHASE BANK, N.A. 2022-09-29 US claimed
CN-115023215-A Formulations providing long-lasting fragrance performance 弗门尼舍有限公司 2022-09-06 CN claimed
EP-3979979-A1 COATING COMPOSITIONS Coty Inc. (US) 2022-04-13 EP claimed
WO-2019156708-A1 FRAGRANCE COMPOSITIONS AND USES THEREOF COTY INC. (US) 2019-08-15 WO claimed
US-20190175457-A1 THREE-DIMENSIONAL MOLDING TYPE POWDER MAKEUP COSMETIC COMPOSITION COSON CO., LTD (KR) 2019-06-13 US claimed
US-10130710-B2 Formulation and method for producing same SEKISUI CHEMICAL CO., LTD. (JP) 2018-11-20 US claimed
EP-3287125-A1 FORMULATION AND METHOD FOR PRODUCING SAME SEKISUI CHEMICAL CO., LTD. (JP) 2018-02-28 EP claimed
US-20170232106-A1 FORMULATION AND METHOD FOR PRODUCING SAME SEKISUI CHEMICAL CO., LTD. (JP) 2017-08-17 US claimed
EP-3195859-A1 FORMULATION AND METHOD FOR PRODUCING SAME Sekisui Chemical Co., Ltd. (JP) 2017-07-26 EP claimed
EP-3103431-A1 FRAGRANCE COMPOSITIONS AND USES THEREOF The Procter and Gamble Company (US) 2016-12-14 EP claimed
EP-3103523-A1 ABSORBENT ARTICLE COMPRISING FRAGRANCE COMPOSITION The Procter and Gamble Company (US) 2016-12-14 EP claimed
US-20110104089-A1 COMPOSITIONS COMPRISING FRAGRANCE SUBSTANCES AND NEOPENTYL GLYCOL DIISONONANOATE SYMRISE AG (DE) 2011-05-05 US claimed
EP-2158896-A2 Materials containing aromas incorporating neopentyl glycol isononanoate Symrise GmbH & Co. KG (DE) 2010-03-03 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220304914-A1 COATING COMPOSITIONS OR10J3, OR51E2, TAS2R20 MAPT 3104/4885DGKA 2551/4885P2RY10 718/4885
US-12508218-B2 Coating compositions TAS2R40, TAS2R20, TAS2R10 MAPT 1419/4885DGKA 2369/4885P2RY10 345/4885
US-20110104089-A1 COMPOSITIONS COMPRISING FRAGRANCE SUBSTANCES AND NEOPENTYL GLYCOL DIISONONANOATE CUTA, KIT, DEGS1 MAPT 3906/4885DGKA 16/4885P2RY10 1827/4885
US-20230098760-A1 FORMULATIONS PROVIDING LONG-LASTING FRAGRANCE PERFORMANCE TRPC5, TRPA1, CYP3A5 MAPT 2633/4885DGKA 1737/4885P2RY10 868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.